Search Results

There are 3922 results for: content related to: A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report

  1. You have free access to this content
    Different mechanisms of Campath-1H-mediated depletion for CD4+ and CD8+ T cells in peripheral blood

    Transplant International

    Volume 19, Issue 11, November 2006, Pages: 927–936, Hayden Lowenstein, Akeesha Shah, Alan Chant and Abrar Khan

    Version of Record online : 4 SEP 2006, DOI: 10.1111/j.1432-2277.2006.00382.x

  2. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients

    Pediatric Transplantation

    Volume 8, Issue 2, April 2004, Pages: 106–112, Stuart J. Knechtle

    Version of Record online : 26 MAR 2004, DOI: 10.1046/j.1399-3046.2003.00139.x

  3. You have free access to this content
    CD52 ligation induces CD4 and CD8 down modulation in vivo and in vitro

    Transplant International

    Volume 19, Issue 9, September 2006, Pages: 749–758, Akeesha Shah, Hayden Lowenstein, Alan Chant and Abrar Khan

    Version of Record online : 20 JUN 2006, DOI: 10.1111/j.1432-2277.2006.00350.x

  4. You have free access to this content
    CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath-1H

    American Journal of Transplantation

    Volume 8, Issue 4, April 2008, Pages: 793–802, D. D. Bloom, Z. Chang, J. H. Fechner, W. Dar, S. P. Polster, J. Pascual, L. A. Turka and S. J. Knechtle

    Version of Record online : 5 FEB 2008, DOI: 10.1111/j.1600-6143.2007.02134.x

  5. You have free access to this content
    Campath-1H Use in Pediatric Renal Transplantation

    American Journal of Transplantation

    Volume 5, Issue 6, June 2005, Pages: 1569–1573, Sharon M. Bartosh, Stuart J. Knechtle and Hans W. Sollinger

    Version of Record online : 11 MAY 2005, DOI: 10.1111/j.1600-6143.2005.00879.x

  6. Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection

    Pediatric Transplantation

    Volume 16, Issue 3, May 2012, Pages: 286–293, Kiran Upadhyay, Laurie Midgley and Asha Moudgil

    Version of Record online : 24 NOV 2011, DOI: 10.1111/j.1399-3046.2011.01615.x

  7. You have free access to this content
    The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment

    British Journal of Haematology

    Volume 107, Issue 1, October 1999, Pages: 148–153, Rawstron, Rollinson, Richards, Short, English, Morgan, Hale and Hillmen

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01676.x

  8. You have free access to this content
    Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis

    European Journal of Immunology

    Volume 35, Issue 11, November 2005, Pages: 3332–3342, Amanda L. Cox, Sara A. J. Thompson, Joanne L. Jones, Vicki H. Robertson, Geoff Hale, Herman Waldmann, D. Alastair S. Compston and Alasdair J. Coles

    Version of Record online : 17 OCT 2005, DOI: 10.1002/eji.200535075

  9. You have free access to this content
    The effect of treatment with Campath-1H in patients with autoimmune cytopenias

    British Journal of Haematology

    Volume 114, Issue 4, September 2001, Pages: 891–898, F. Willis, 1 J. C. W. Marsh, 1 D. H. Bevan, 1 S. B. Killick, 1 G. Lucas, 2 R. Griffiths, 2 W. Ouwehand, 3 G. Hale, 4 H. Waldmann and 4 E. C. Gordon-smith 1

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2141.2001.03039.x

  10. You have free access to this content
    Acute Cellular Rejection Predominated by Monocytes Is a Severe Form of Rejection in Human Renal Recipients With or Without Campath-1H (Alemtuzumab) Induction Therapy

    American Journal of Transplantation

    Volume 5, Issue 3, March 2005, Pages: 604–607, Ping L. Zhang, Sayeed K. Malek, Jeffery W. Prichard, Fan Lin, Taher M. Yahya, Michael S. Schwartzman, Ruth P. Latsha, Evan R. Norfolk, Thomas M. Blasick, Mingyue Lun, Robert E. Brown, James E. Hartle and Santosh Potdar

    Version of Record online : 16 DEC 2004, DOI: 10.1111/j.1600-6143.2004.00712.x

  11. You have free access to this content
    Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells

    Immunology

    Volume 95, Issue 3, November 1998, Pages: 427–436, ROWAN, TITE, TOPLEY and BRETT

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2567.1998.00615.x

  12. You have free access to this content
    Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia

    Arthritis & Rheumatism

    Volume 44, Issue 9, September 2001, Pages: 1998–2008, John D. Isaacs, Sandra Greer, Shunil Sharma, Deborah Symmons, Mary Smith, Jeffrey Johnston, Herman Waldmann, Geoff Hale and Brian L. Hazleman

    Version of Record online : 26 SEP 2001, DOI: 10.1002/1529-0131(200109)44:9<1998::AID-ART348>3.0.CO;2-T

  13. You have free access to this content
    WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS

    American Journal of Transplantation

    Volume 6, Issue s2, August 2006, Pages: 473–1061,

    Version of Record online : 11 AUG 2006, DOI: 10.1111/j.1600-6143.2006.01447.x

  14. You have free access to this content
    Abstracts

    American Journal of Transplantation

    Volume 5, Issue s11, May 2005, Pages: 155–576,

    Version of Record online : 12 MAY 2005, DOI: 10.1111/j.1600-6135.2005.abstracts.x

  15. Monoclonal Antibodies in Chronic Lymphocytic Leukemia

    Reviews in Clinical and Experimental Hematology

    Volume 4, Issue 2, June 2000, Pages: 134–144, Kanti R. Rai and Niraj Gupta

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1468-0734.2000.00010.x

  16. Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD

    European Journal of Haematology

    Volume 72, Issue 2, February 2004, Pages: 145–148, Daniel Wolff, B. Steiner, S. Stilgenbauer, C. Kahl, M. Leithäuser, C. Junghanss, S. Wilhelm, H. D. Kleine, R. Zimmermann, G. Hartung, J. Casper and M. Freund

    Version of Record online : 6 JAN 2004, DOI: 10.1046/j.0902-4441.2003.00181.x

  17. Clonal CD8+ and CD52 T cells are induced in responding B cell lymphoma patients treated with Campath-1H* (anti-CD52)

    European Journal of Haematology

    Volume 58, Issue 1, January 1997, Pages: 5–13, A. Österborg, Å. Werner, E. Halapi, J. Lundin, U. Harmenberg, H. Wigzell and H. Mellstedt

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1997.tb01403.x

  18. A comparison of Campath and Thymoglobulin as part of the conditioning before allogeneic hematopoietic stem cell transplantation

    European Journal of Haematology

    Volume 86, Issue 1, January 2011, Pages: 57–66, Anna-Carin Norlin and Mats Remberger

    Version of Record online : 25 NOV 2010, DOI: 10.1111/j.1600-0609.2010.01537.x

  19. You have free access to this content
    Campath-1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 38, Issue 11, November 1995, Pages: 1589–1594, Michael E. Weinblatt, Peter J. Maddison, Ken J. Bulpitt, Brian L. Hazleman, Murray B. Urowitz, Roger D. Sturrock, Jonathan S. Coblyn, Agnes L. Maier, William R. Spreen, Vasant K. Manna and Jeffrey M. Johnston

    Version of Record online : 9 DEC 2005, DOI: 10.1002/art.1780381110

  20. You have free access to this content
    Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

    British Journal of Haematology

    Volume 96, Issue 3, March 1997, Pages: 617–619, A. L. Bowen, A. Zomas, E. Emmett, E. Matutes, M. J. S. Dyer and D. Catovsky

    Version of Record online : 29 OCT 2003, DOI: 10.1046/j.1365-2141.1997.d01-2061.x